Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Wong

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Chemistry and Laboratory Medicine|December 4, 2004
Pharmacogenomic genotyping methodologiesPaul J Jannetto, Elvan Laleli-Sahin, Steven H Wong
Journal of Analytical Toxicology|January 20, 2006
Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl casesMing Jin, Susan B Gock, Paul J Jannetto, et al.
Journal of Analytical Toxicology|November 9, 2002
Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone casesPaul J Jannetto, Steven H Wong, Susan B Gock, et al.
Journal of Forensic Sciences|December 3, 2003
Pharmacogenomics as an aspect of molecular autopsy for forensic pathology/toxicology: does genotyping CYP 2D6 serve as an adjunct for certifying methadone toxicity?Steven H Wong, Michael A Wagner, Jeffrey M Jentzen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 18, 2006
Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolismHong-Kee Lee, Lionel D Lewis, Gregory J Tsongalis, et al.
Clinical Chemistry|March 17, 2007
Validation of a CYP2D6 genotyping panel on the NanoChip Molecular Biology WorkstationHong-Kee Lee, Lionel D Lewis, Gregory J Tsongalis, et al.
Clinical Chemistry|January 1, 2016
Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based AssaysAndrew N Hoofnagle, Jeffrey R Whiteaker, Steven A Carr, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Chemistry and Laboratory Medicine|December 4, 2004
Pharmacogenomic genotyping methodologiesPaul J Jannetto, Elvan Laleli-Sahin, Steven H Wong
Journal of Analytical Toxicology|January 20, 2006
Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl casesMing Jin, Susan B Gock, Paul J Jannetto, et al.
Journal of Analytical Toxicology|November 9, 2002
Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone casesPaul J Jannetto, Steven H Wong, Susan B Gock, et al.
Journal of Forensic Sciences|December 3, 2003
Pharmacogenomics as an aspect of molecular autopsy for forensic pathology/toxicology: does genotyping CYP 2D6 serve as an adjunct for certifying methadone toxicity?Steven H Wong, Michael A Wagner, Jeffrey M Jentzen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 18, 2006
Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolismHong-Kee Lee, Lionel D Lewis, Gregory J Tsongalis, et al.
Clinical Chemistry|March 17, 2007
Validation of a CYP2D6 genotyping panel on the NanoChip Molecular Biology WorkstationHong-Kee Lee, Lionel D Lewis, Gregory J Tsongalis, et al.
Clinical Chemistry|January 1, 2016
Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based AssaysAndrew N Hoofnagle, Jeffrey R Whiteaker, Steven A Carr, et al.
Pageof 1